Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Hepatol ; 66(6): 1149-1157, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28213165

RESUMO

BACKGROUND & AIMS: Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) persists as a stable episome in infected hepatocytes and serves as a template for the transcription of all viral genes. Due to the narrow host range of HBV, the development of a robust mouse model that supports cccDNA-dependent viral replication is a key hurdle in the development of novel HBV therapeutics. This study aimed to develop a novel tool to investigate HBV cccDNA. METHODS: Through minicircle technology, HBVcircle, a recombinant cccDNA, was easily generated and extracted from a genetically engineered E. coli strain. We characterized the performance of HBVcircle in cell culture by transfection and in immunocompetent mice by hydrodynamic injection (HDI). RESULTS: We demonstrated that HBVcircle formed authentic cccDNA-like molecules in vitro in transiently transfected hepatic cells and in vivo in mouse liver after HDI. HBVcircle supported high levels and persistent HBV replication. In addition, we investigated different factors affecting HBV in vivo replication and persistence, including the host genetic background, vector design and dosage, viral genes and genotypes, and immune activation status. Furthermore, different classes of anti-HBV drugs were also assessed with the HBVcircle system. CONCLUSION: Compared with previous reported HBV mouse models which employ other viral vectors to introduce overlength HBV genomes, viral gene expression and associated phenotypes are entirely driven by cccDNA-like viral genomes in the HBVcircle mouse model. Therefore, the HBVcircle is a close mimic of cccDNA, and it represents a novel tool for addressing HBV cccDNA related biological questions and for anti-HBV drug discovery. LAY SUMMARY: To establish a mouse model that supports cccDNA-dependent transcription, a novel tool named HBVcircle, was developed with minicircle technology. HBVcircle formed authentic cccDNA-like molecules in hepatocytes, and supported high levels and persistent HBV replication in vivo. The HBVcircle is a close mimic of cccDNA, and it represents a novel tool for addressing HBV cccDNA related biological questions and for anti-HBV drug discovery.


Assuntos
DNA Circular/genética , DNA Viral/genética , Técnicas Genéticas , Vírus da Hepatite B/genética , Imunidade Adaptativa , Animais , Linhagem Celular , DNA Circular/biossíntese , DNA Circular/imunologia , DNA Viral/biossíntese , DNA Viral/imunologia , Descoberta de Drogas , Avaliação Pré-Clínica de Medicamentos , Genes Virais , Engenharia Genética , Células Hep G2 , Hepatite B/tratamento farmacológico , Hepatite B/virologia , Vírus da Hepatite B/imunologia , Vírus da Hepatite B/fisiologia , Hepatócitos/virologia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C3H , Modelos Genéticos , Transcrição Gênica , Transfecção , Replicação Viral/genética
2.
Int Immunopharmacol ; 10(3): 290-7, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19951747

RESUMO

Physalis angulata is an annual herb widely used in folk medicine. It is mainly used for treating rheumatoid arthritis (RA). Following bioactivity-guided isolation, a representative immunosuppressive compound, Physalin H was been identified from this herb medicine. The purpose of this work was to assess the immunosuppressive activity of Physalin H on T cells and to explore its potential mode of action. The results showed that Physalin H in a dose-dependent manner significantly inhibited the proliferation of T cells induced by concanavalin A (ConA) and by the mixed lymphocyte culture reaction (MLR). This inhibitive activity was mainly due to interfering DNA replication in G1 stages. In vivo experiments showed that, administration of Physalin H dose-dependently suppressed CD4(+) T cell mediated delayed-type hypersensitivity (DTH) reactions, and suppressed antigen-specific T-cell response in ovalbumin (OVA) immunized mice. Further study indicated that Physalin H could modulate Th1/Th2 cytokine balance and induce the production of immune regulation target Heme oxygenase (HO)-1 in T-cells in vitro. In this study, we demonstrated the immunosuppressive effect of Physalin H on T cells both in vitro and in vivo, and the immunosuppressive activity might be attributed to the suppression of T cell activation and proliferation, the modulation of Th1/Th2 cytokine balance and the induction of HO-1 in T cells.


Assuntos
Imunossupressores , Secoesteroides/farmacologia , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia , Animais , Western Blotting , Proliferação de Células/efeitos dos fármacos , Corantes , Concanavalina A/farmacologia , Dinitrofluorbenzeno/farmacologia , Ensaio de Imunoadsorção Enzimática , Citometria de Fluxo , Heme Oxigenase-1/biossíntese , Hipersensibilidade Tardia/imunologia , Imunidade Celular/efeitos dos fármacos , Indicadores e Reagentes , Teste de Cultura Mista de Linfócitos , Camundongos , Camundongos Endogâmicos BALB C , Ovalbumina/imunologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Baço/citologia , Sais de Tetrazólio , Tiazóis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA